Combined action of type I and type III interferon restricts initial replication of severe acute respiratory syndrome coronavirus in the lung but fails to inhibit systemic virus spread

被引:46
|
作者
Mahlakoiv, Tanel [1 ,2 ]
Ritz, Daniel [3 ]
Mordstein, Markus [1 ,2 ]
DeDiego, Marta L. [4 ]
Enjuanes, Luis [4 ]
Mueller, Marcel A. [3 ]
Drosten, Christian [3 ]
Staeheli, Peter [1 ]
机构
[1] Univ Freiburg, Dept Virol, D-79104 Freiburg, Germany
[2] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany
[3] Univ Bonn, Inst Virol, Med Ctr, D-53127 Bonn, Germany
[4] CSIC, CNB, Dept Mol & Cell Biol, E-28049 Madrid, Spain
来源
关键词
IFN-LAMBDA; SYNDROME SARS; INFECTION; RECEPTOR; INVOLVEMENT; PATHWAY;
D O I
10.1099/vir.0.046284-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
STAT1-deficient mice are more susceptible to infection with severe acute respiratory syndrome coronavirus (SARS-CoV) than type I interferon (IFN) receptor-deficient mice. We used mice lacking functional receptors for both type I and type III IFN (double knockout, dKO) to evaluate the possibility that type III IFN plays a decisive role in SARS-CoV protection. We found that viral peak titres in lungs of dKO and STAT1-deficient mice were similar, but significantly higher than in wild-type mice. The kinetics of viral clearance from the lung were also comparable in dKO and STAT1-deficient mice. Surprisingly, however, infected dKO mice remained healthy, whereas infected STAT1-deficient mice developed liver pathology and eventually succumbed to neurological disease. Our data suggest that the failure of STAT1-deficient mice to control initial SARS-CoV replication efficiently in the lung is due to impaired type I and type III IFN signalling, whereas the failure to control subsequent systemic viral spread is due to unrelated defects in STAT1-deficient mice.
引用
收藏
页码:2601 / 2605
页数:5
相关论文
共 32 条
  • [21] Host inhibits replication of European porcine reproductive and respiratory syndrome virus in macrophages by altering differential regulation of type-I interferon transcriptional response
    Tahar Ait-Ali
    Alison D. Wilson
    Wilfrid Carré
    David G. Westcott
    Jean-Pierre Frossard
    Marnie A. Mellencamp
    Daphne Mouzaki
    Oswald Matika
    David Waddington
    Trevor W. Drew
    Stephen C. Bishop
    Alan L. Archibald
    Immunogenetics, 2011, 63 : 437 - 448
  • [22] Host inhibits replication of European porcine reproductive and respiratory syndrome virus in macrophages by altering differential regulation of type-I interferon transcriptional response
    Ait-Ali, Tahar
    Wilson, Alison D.
    Carre, Wilfrid
    Westcott, David G.
    Frossard, Jean-Pierre
    Mellencamp, Marnie A.
    Mouzaki, Daphne
    Matika, Oswald
    Waddington, David
    Drew, Trevor W.
    Bishop, Stephen C.
    Archibald, Alan L.
    IMMUNOGENETICS, 2011, 63 (07) : 437 - 448
  • [23] PP2A Facilitates Porcine Reproductive and Respiratory Syndrome Virus Replication by Deactivating irf3 and Limiting Type I Interferon Production
    Xu, Jiayu
    Zhang, Lu
    Xu, Yunfei
    Zhang, He
    Gao, Junxin
    Wang, Qian
    Tian, Zhijun
    Xuan, Lv
    Chen, Hongyan
    Wang, Yue
    VIRUSES-BASEL, 2019, 11 (10):
  • [24] Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus and Viral RNA in Relation to Surface Type and Contamination Concentration
    Paton, Susan
    Spencer, Antony
    Garratt, Isobel
    Thompson, Katy-Anne
    Dinesh, Ikshitaa
    Aranega-Bou, Paz
    Stevenson, David
    Clark, Simon
    Dunning, Jake
    Bennett, Allan
    Pottage, Thomas
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2021, 87 (14) : 1 - 9
  • [25] The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Inhibits Type I Interferon Production by Interfering with TRIM25-Mediated RIG-I Ubiquitination (vol 91, pg e02143-16, 2017)
    Hu, Yong
    Li, Wei
    Gao, Ting
    Cui, Yan
    Jin, Yanwen
    Li, Ping
    Ma, Qingjun
    Liu, Xuan
    Cao, Cheng
    JOURNAL OF VIROLOGY, 2020, 94 (20)
  • [26] Type I Interferon and TRAIL (TNF-related apoptosis-inducing ligand) inhibit alveolar Liquid-Clearance in Influenza A Virus induced acute Lung Injury
    Becker, C.
    Morales-Nebreda, L.
    Lecuona, E.
    Vadasz, I.
    Wolff, T.
    Morty, R.
    Lohmeyer, J.
    Seeger, W.
    Sznajder, J.
    Mutlu, G.
    Budinger, S.
    Herold, S.
    INTERNIST, 2015, 56 : 4 - 5
  • [27] Phage display technique identifies the interaction of severe acute respiratory syndrome coronavirus open reading frame 6 protein with nuclear pore complex interacting protein NPIPB3 in modulating Type I interferon antagonism
    Huang, Su-Hua
    Lee, Tzu-Ying
    Lin, Ying-Ju
    Wan, Lei
    Lai, Chih-Ho
    Lin, Cheng-Wen
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2017, 50 (03) : 277 - 285
  • [28] Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus
    Subramanian, G. Mani
    Moore, Paul A.
    Gowen, Brian B.
    Olsen, Aaron L.
    Barnard, Dale L.
    Paragas, Jason
    Hogan, Robert J.
    Sidwell, Robert W.
    CHEMOTHERAPY, 2008, 54 (03) : 176 - 180
  • [29] Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
    Deng Jie-Lin
    Jiang Yun-Qiu
    Guo Yan-Kai
    Li Hong-Liang
    中华医学杂志英文版, 2020, 133 (22) : 2650 - 2652
  • [30] Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
    Deng, Jie-Lin
    Jiang, Yun-Qiu
    Guo, Yan-Kai
    Li, Hong-Liang
    CHINESE MEDICAL JOURNAL, 2020, 133 (22) : 2650 - 2652